Results 241 to 250 of about 4,241,016 (384)

Utilizing T-Lymphocyte Activation-Related Cytokines to Predict Non-Responsiveness to Treatment in Pediatric Kawasaki Disease. [PDF]

Pediatric Health Med Ther
Ye B, Xiao J, Zhang C.
europepmc   +1 more source

Lymphocyte Activation Gene 3 Single-Nucleotide Polymorphisms in Bone Marrow Failure Diseases. [PDF]

Anal Cell Pathol (Amst), 2022
Sun Y, Cao Q, Zhao X, Liu C, Shao Z.
europepmc   +1 more source

Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. [PDF]

, 1987
WF Rigby, Sylvia A. Denome, Michael W. Fanger   +2 more
openalex   +1 more source

Suppressing t(4;11) Acute Leukemia by Lipopolymer Nanoparticle Delivery of siRNA Targeting KMT2A::AFF1 with Enhanced Extrahepatic Delivery

Advanced Healthcare Materials, EarlyView.
This study introduces a new lipopolymer nanoparticle (LPNP) system that efficiently delivers siRNA to leukemia cells. The LPNPs silence the leukemia fusion gene KMT2A::AFF1, induce apoptosis, and decrease leukemia burden in mice. These results demonstrate the potential of LPNPs as a targeted siRNA therapy for acute lymphoblastic leukemia.
Mohammad Nasrullah, Remant KC, Amarnath Praphakar Rajendran, Saba Abbasi Dezfouli, Cezary Kucharski, Xiaoyan Jiang, Spencer B. Gibson, Joseph Brandwein, Olaf Heidenreich, Hasan Uludağ   +9 more
wiley   +1 more source

Akkermansia muciniphila- and Pathogenic Bacteria-Derived Endotoxins Differently Regulate Human Dendritic Cell Generation and γδ T Lymphocyte Activation. [PDF]

Biomolecules
Fertitta V, Varano B, Del Cornò M, Fortini P, Aureli A, Conti L.   +5 more
europepmc   +1 more source

The Role of Protein and Lipid Clustering in Lymphocyte Activation. [PDF]

Front Immunol, 2021
Lamerton RE, Lightfoot A, Nieves DJ, Owen DM.   +3 more
europepmc   +1 more source

Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells. [PDF]

, 1983
Elizabeth A. Grimm, R J Robb, Jack A. Roth, L M Neckers, Lawrence B. Lachman, Debra J. Wilson, Steven A. Rosenberg   +6 more
openalex   +1 more source

CD69: from activation marker to metabolic gatekeeper

European Journal of Immunology, 2017
Danay Cibrian, F. Sánchez‐Madrid
semanticscholar   +1 more source

Advanced Nanoparticle Therapeutics for Targeting Neutrophils in Inflammatory Diseases

Advanced Healthcare Materials, EarlyView.
This review highlights recent advances in nanoparticle‐based strategies to modulate neutrophil activity in inflammatory diseases. By targeting inflammatory neutrophils, NET formation, and neutrophil apoptosis or recruitment, these approaches aim to improve therapeutic precision.
Min Ji Byun, Elizabeth S. Nakasone, Ha Eun Shin, Hyojin Lee, Jong‐Chan Park, Wonhwa Lee, Wooram Park, Chun Gwon Park, Juwon Park, Se‐Na Kim   +9 more
wiley   +1 more source

A serum B-lymphocyte activation signature is a key distinguishing feature of the immune response in sarcoidosis compared to tuberculosis. [PDF]

Commun Biol
Putera I, Schrijver B, Kolijn PM, van Stigt AC, Ten Berge JCEM, IJspeert H, Nagtzaam NMA, Swagemakers SMA, van Laar JAM, Agrawal R, Rombach SM, van Hagen PM, La Distia Nora R, Dik WA.   +13 more
europepmc   +1 more source